Immunization, measles second dose in OECD members
OECD members: Immunization, measles second dose was 87.9% in 2024. ▲ Rising
Immunization, measles second dose in OECD members, 2000–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children by the nationally recommended age.
Analysis
The most recent figure for immunization, measles second dose in OECD members is 87.9%, measured in 2024.
That represents a change of down 0.3% on the previous year and down 3.0% over ten years.
Over the whole period, immunization, measles second dose in OECD members peaked at 92.4% in 2021 and was at its lowest, 48.8%, in 2000.
That places OECD members 11th out of 43 groups with data for 2024, putting it in the top quarter.
The long-run direction has been consistently rising across the 25 years of available data.
Immunization, measles second dose in OECD members, year by year
| Year | % of children by the nationally recommended age | Change |
|---|---|---|
| 2000 | 48.8% | — |
| 2001 | 58.9% | +20.7% |
| 2002 | 63.6% | +8.0% |
| 2003 | 65.0% | +2.1% |
| 2004 | 70.6% | +8.7% |
| 2005 | 71.2% | +0.8% |
| 2006 | 70.7% | -0.7% |
| 2007 | 71.5% | +1.2% |
| 2008 | 77.3% | +8.0% |
| 2009 | 78.0% | +0.9% |
| 2010 | 82.0% | +5.1% |
| 2011 | 83.1% | +1.3% |
| 2012 | 85.1% | +2.4% |
| 2013 | 86.8% | +1.9% |
| 2014 | 90.7% | +4.5% |
| 2015 | 90.8% | +0.1% |
| 2016 | 91.5% | +0.8% |
| 2017 | 86.9% | -5.0% |
| 2018 | 92.1% | +6.0% |
| 2019 | 86.7% | -5.9% |
| 2020 | 90.1% | +4.0% |
| 2021 | 92.4% | +2.5% |
| 2022 | 90.1% | -2.5% |
| 2023 | 88.2% | -2.1% |
| 2024 | 87.9% | -0.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 67.5% | 48.8% | 78.0% | 10 |
| 2010s | 87.6% | 82.0% | 92.1% | 10 |
| 2020s | 89.8% | 87.9% | 92.4% | 5 |
More health data for OECD members
- Population ages 40-44, male, per capita 0.0336 units per person (2025)
- Population ages 45-49, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, male, annual growth rate 0.5497 % change on previous year (2025)
- Population ages 45-49, female, per capita 0.0329 units per person (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, annual growth rate 0.5518 % change on previous year (2025)
- Population ages 40-44, male, annual growth rate -0.0796 % change on previous year (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, per capita 0.0334 units per person (2025)
Frequently asked questions
- What is immunization, measles second dose in OECD members?
- Immunization, measles second dose in OECD members was 87.9% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, measles second dose recorded in OECD members?
- The highest recorded value was 92.4% in 2021.
- What is the lowest immunization, measles second dose recorded in OECD members?
- The lowest recorded value was 48.8% in 2000.
- How does OECD members rank for immunization, measles second dose?
- OECD members ranks 11th out of 43 groups with data for 2024.
- Is immunization, measles second dose rising or falling in OECD members?
- Over the last ten years it is down 3.0%. The long-run trend across the full record is rising.
- Where does this OECD members data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, measles second dose (% of children by the nationally recommended age). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.